Swiss global health-care firm Roche has launched a global access programme for HIV viral load testing to combat AIDS, tuberculosis (TB) and malaria.

The programme has been created in partnership with UNAIDS, the joint United Nations Programme on HIV/AIDS, the Clinton Health Access Initiative (CHAI), the President’s Emergency Plan For AIDS Relief (PEPFAR) and the Global Fund.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The company has committed to provide its COBAS AmpliPrep/COBAS TaqMan HIV-1 Test version 2.0 through a special pricing scheme for qualifying organisations in eligible countries in order to support the global access programme.

The programme has been designed as part of the diagnostics access initiative, which will involve in expanding laboratory capacity to help people living with HIV in receiving high-quality HIV treatment services.

"The global access programme is a major step forward in improving the quality of care for HIV patients and preventing further transmission of the disease."

This initiative was launched during the 20th International AIDS conference in July 2014.

See Also:

CHAI access programmes executive vice-president David Ripin said: "The global access programme is a major step forward in improving the quality of care for HIV patients and preventing further transmission of the disease.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

"This is an admirable and rapid response to the challenge issued by UNAIDS at the 2014 AIDS Conference to increase access to high quality treatment to patients living with HIV and AIDS.

"CHAI is proud to be part of this partnership, and looks forward to working with Roche, governments and partners to ensure that the terms of the program translate to increased patient access."

There were 35 million people living with HIV around the world in 2012, accordingly to the World Health Organization (WHO).

Roche Diagnostics chief operating officer Roland Diggelmann said: "As the leader in HIV viral load testing, Roche supports the UNAIDS 90:90:90 goal and the diagnostics access initiative by expanding access to quality HIV testing through affordable pricing to those countries hardest hit by the disease.

"With 70% of all people living with HIV residing in Sub-Saharan Africa, we believe our commitment can truly make a difference to UNAIDS’s goal for achieving control of the HIV/AIDS epidemic."